We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Genetic Epidemiology of Adult Onset Glioma

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00283569
First Posted: January 30, 2006
Last Update Posted: January 20, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
DR. Kathleen Egan
Information provided by:
Kentuckiana Cancer Institute
  Purpose
To establish a clinic based case control study for examination of potential risk factors for primary adult brain tumors.

Condition Intervention
Adult-Onset Glioma Other: Mouth Swab, Toe Nail Clippings, Questionnaires

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Genetic Epidemiology of Adult-Onset Glioma

Resource links provided by NLM:


Further study details as provided by Kentuckiana Cancer Institute:

Biospecimen Retention:   Samples With DNA
Saliva, Toe Nail Clippings

Estimated Enrollment: 100
Study Start Date: May 2004
Study Completion Date: January 2010
Primary Completion Date: January 2010 (Final data collection date for primary outcome measure)
Intervention Details:
    Other: Mouth Swab, Toe Nail Clippings, Questionnaires
    The objective of this study is to establish a clinic based case control study for examination of potential risk factors for primary adult brain tumors.
Detailed Description:
Genetic epidemiology of adult glioma to establish potential risk factors for primary adult brain tumors.
  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population
Patients with Glioma and a Control
Criteria

Inclusion Criteria:

  • primary glioma of any stage
  • diagnosed within 4 months
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00283569


Locations
United States, Kentucky
Kentuckiana Cancer Institute
Louisville, Kentucky, United States, 40202
Sponsors and Collaborators
Kentuckiana Cancer Institute
DR. Kathleen Egan
Investigators
Principal Investigator: Renato V. LaRocca, MD Director
  More Information

Responsible Party: Renato V. LaRocca, MD, Kentuckiana Cancer Institute
ClinicalTrials.gov Identifier: NCT00283569     History of Changes
Other Study ID Numbers: mrbt1-03-132
MRBTC2003-01
First Submitted: January 26, 2006
First Posted: January 30, 2006
Last Update Posted: January 20, 2010
Last Verified: January 2010

Keywords provided by Kentuckiana Cancer Institute:
Glioma

Additional relevant MeSH terms:
Glioma
Neoplasms, Neuroepithelial
Neuroectodermal Tumors
Neoplasms, Germ Cell and Embryonal
Neoplasms by Histologic Type
Neoplasms
Neoplasms, Glandular and Epithelial
Neoplasms, Nerve Tissue